Badger Meter, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMI research report →
Range $112 – $167
Price Chart
About the company
Badger Meter, Inc. (BMI) provides a comprehensive range of solutions for flow measurement, quality assessment, control, and communication. Operating globally, the company serves markets across North America, Europe, Asia, and the Middle East.
- CEO
- Kenneth C. Bockhorst
- IPO
- 1983
- Employees
- 2,477
- HQ
- Milwaukee, WI, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a corrective regime after a major run, trading well below its 200-day and 50-day moving averages. It is also far off the 52-week high, though still above the 52-week low, which points to a damaged but not broken long-term trend.
Street sentiment is mixed-to-cautious: consensus sits at Hold with 5 Buys, 10 Holds, and 3 Sells. The average target has been pulled around recently but still implies upside from current levels, while the latest calls show several target cuts alongside Barclays’ Underweight stance and a few constructive reiterations.
The next print comes after a choppy stretch: 3 of the last 7 quarters were beats, but the most recent two completed quarters were mixed. EPS estimates for next year rise to 4.9812 from a 4.24 TTM base, so shareholders should watch whether margin discipline and municipal demand can re-accelerate results.
Recent insider activity leans constructive. The only clear discretionary signals were three open-market purchases by officers, while the rest of the activity was awards and discretionary compensation-related grants, which are less informative. No insider selling stands out in the recent window.
Profitability remains solid, with gross margin at 41.3%, operating margin at 17.72%, and net margin at 14.27%. Growth has softened, with revenue down 6.6% year over year and earnings down 12.8%, but free cash flow of $197.7 million and $226.0 million of cash leave the balance sheet flexible.
Badger Meter still screens as a premium-quality industrial tech name, supported by 18.48% ROE and 10.58% ROA. The setup favors a valuation above many peers, but the current multiple remains sensitive to whether growth can catch up with the company’s historically strong margins.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.81B
- P/E
- 30.65
- Fwd P/E
- 29.54
- PEG
- -4.17
- P/S
- 4.33
- P/B
- 5.59
- EV/EBITDA
- 18.77
- Div Yield
- 1.25%
- Gross Margin
- 41.31%
- Op Margin
- 18.58%
- Net Margin
- 14.27%
- ROE
- 18.03%
- ROIC
- 14.81%
Latest fiscal year · YoY change
- Revenue
- $916.66M+10.9%
- Gross Profit
- $382.07M+16.1%
- Op Income
- $183.42M
- Net Income
- $141.63M+13.4%
- EPS
- $4.82+13.1%
- OCF Growth
- +18.5%
- FCF Growth
- +19.3%
- 52W High
- $204.00
- 52W Low
- $112.09
- 50D MA
- $134.16
- 200D MA
- $145.28
- Beta
- 0.64
- RSI (14)
- 51
- Avg Volume
- 439.16K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Badger Meter said Q2 sales and EPS declined year over year, but management pointed to sequential improvement, early project ramps, and reaffirmed a flattish full-year organic revenue outlook.· July 22, 2026
- Q2 sales were $222.3 million, down 7% year over year; diluted EPS was $1.02, down 13% from $1.17.
- Gross margin was 40.8%, down 30 basis points, while operating margin fell to 17.7% as lower volume and project mix pressured profitability.
- Base sales improved 9% sequentially versus Q1, helped by early shipment ramps on awarded AMI projects and stronger flow instrumentation demand.
- Management reaffirmed full-year 2026 organic revenue as roughly flattish versus 2025, with sequential improvement expected through the rest of the year and growth weighted to Q4.
- Cash generation remained solid: free cash flow was $21.9 million, shares repurchased totaled $25.3 million, and the company ended with an undrawn $150 million credit facility.
Total sales in Q2 were $222.3 million, down 7% year over year; excluding UDlive, base sales were down 7.5% year over year and 9% higher sequentially versus Q1. Utility water sales declined 8% year over year, while flow instrumentation sales rose 6%. Gross margin was 40.8%, down 30 basis points year over year; operating earnings declined 12% and operating margin was 17.7%, down 110 basis points. Base operating profit margin, excluding UDlive, was 18.4%, down 40 basis points. Diluted EPS was $1.02 versus $1.17 last year, and the effective tax rate was 25.2% versus 24.5%. Free cash flow was $21.9 million versus $40.6 million last year. For the full year, management still expects organic revenue excluding UDlive to be roughly flattish versus 2025, with sequential improvement in base quarterly revenue and growth more heavily weighted to Q4. The company also expects UDlive intangible asset amortization of approximately $5 million annually.
Ken Bockhorst said the quarter unfolded largely as expected, with sequential revenue improvement driven by initial ramps in previously awarded AMI projects and a modest pickup in short-term order rates. He emphasized that the full-year outlook is unchanged: organic revenue excluding UDlive should be roughly flattish versus 2025, but not perfectly flat, because project timing and order patterns remain uneven. His tone was confident on the long-term story, citing replacement demand, AMI adoption, recurring software, beyond-the-meter growth, and disciplined execution as durable drivers.
Dan Weltzien highlighted that Q2 sales were $222.3 million, down 7% year over year, while base sales were 9% higher sequentially versus Q1. He cited gross margin of 40.8%, operating margin of 17.7%, base operating margin of 18.4%, and diluted EPS of $1.02, and noted that SG&A was $51.4 million, down $1.6 million year over year due to spending controls and lower incentive compensation. He also pointed to free cash flow of $21.9 million, working capital at 22.9% of sales, $25.3 million of share repurchases in the quarter, about $90 million remaining on the authorization, and a newly renewed five-year $150 million credit facility that remains undrawn.
Analysts focused on whether the second-half ramp looks more visible than 90 days ago, and management said the cohort of nine awarded projects feels solid, though timing remains uneven and not all projects start at once. Questions also centered on electronics cost pressure and whether price can offset it; management said they are managing both cost and availability and can generally recapture increases through pricing and contract escalators, though not perfectly in every case. There was also concern about PRASA and whether any legal or political developments had changed expectations; management said nothing has changed in its view of the project and reiterated it won a fair and open process. Analysts asked about capital allocation and share repurchases, and management said the approach remains balanced between reinvestment, buybacks, dividends, and M&A.
The bull case from this call is that sequential demand is improving, with base sales up 9% from Q1 and multiple awarded AMI projects beginning to ramp. Management also sees durable long-term drivers in the water sector, strong customer and consultant interest in its NaaS and software offerings, and continued ability to manage margins despite electronics pressure.
The main risks are still uneven project timing, weak year-over-year sales, and continued pressure from lower utility water volume and project mix. Management also flagged increasing electronics component cost and availability pressures, and working capital remains elevated at 22.9% of sales, with receivables and inventory tied to timing and pacing.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.4%
- Shares Outstanding
- 28.99M
- Float Shares
- 28.80M
of shares held by institutions
483 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for BMI, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Markwayne MullinSenate · OK | Buy | Jan 4, 24 | Filing → |
| Markwayne MullinSenate · OK | Buy | Jan 4, 24 | Filing → |
| Markwayne MullinSenate · OK | Buy | Jan 4, 24 | Filing → |
| Markwayne MullinSenate · OK | Buy | Jan 4, 24 | Filing → |
| Markwayne MullinSenate · OK | Sell | Dec 18, 24 | Filing → |
| Markwayne MullinSenate · OK | Sell | Dec 18, 24 | Filing → |
| Markwayne MullinSenate · OK | Buy | Jan 4, 24 | Filing → |
| Markwayne MullinSenate · OK | Buy | Jan 4, 24 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 4.89M | ▼ 59.54K |
| Vanguard Group Inc | 3.98M | ▲ 19.59K |
| Vanguard Portfolio Management LLC | 2.50M | ▲ 53.17K |
| State Street Corp | 1.65M | ▲ 126.44K |
| Vanguard Capital Management LLC | 1.32M | ▲ 15.71K |
| Geode Capital Management, LLC | 1.01M | ▲ 69.56K |
| Impax Asset Management Group PLC | 945.69K | ▲ 945.69K |
| First Trust Advisors LP | 771.86K | ▲ 211.51K |
| Morgan Stanley | 739.88K | ▲ 76.69K |
| Boston Trust Walden Corp | 728.96K | ▲ 198.79K |
| Ubs Group AG | 629.41K | ▼ 228.76K |
| Amundi | 590.08K | ▲ 131.02K |
Held by 542 ETFs
Biggest fund positions in BMI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 30, 26 | Callahan Edward F. | buy | 751 |
| Jul 1, 26 | ADAMS TODD A. | other | 128.05 |
| Jul 1, 26 | Liu Xia | other | 128.05 |
| May 1, 26 | Liu Xia | other | 131.28 |
| Apr 27, 26 | Cook Melanie K. | other | 952 |
| Apr 27, 26 | Liu Xia | other | 952 |
| Apr 27, 26 | McGill James W | other | 952 |
| Apr 27, 26 | Myers Tessa M. | other | 952 |
| Apr 27, 26 | TELLOCK GLEN E | other | 952 |
| Apr 27, 26 | Brooks Henry F | other | 952 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BMI coverage
Recent articles, reports, and earnings notes.

Badger Meter (BMI): Quality Compounder, But Richly Valued
Badger Meter combines a strong balance sheet, rising software exposure, and long-term smart water demand, but near-term execution has softened and the stock still screens expensive.

Badger Meter (BMI): Premium Compounder, But Not Cheap
Badger Meter is a high-quality smart water infrastructure compounder with strong revenue growth, expanding margins, and a debt-free balance sheet. The stock looks attractive on quality, but its premium valuation leaves limited margin of safety.

Badger Meter, Inc. (BMI) slips as earnings meets expectations
Badger Meter, Inc. (BMI) slips 3.0% after reporting earnings that meet expectations, as investors react to the latest quarterly results and outlook.
Want a deeper read on BMI?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Badger Meter (BMI) Surges 4.0%: Is This an Indication of Further Gains?
zacks.com · Sep 21
Contrasting Veralto (NYSE:VLTO) and Badger Meter (NYSE:BMI)
defenseworld.net · Sep 21
Badger Meter (BMI) Increases Despite Market Slip: Here's What You Need to Know
zacks.com · Sep 16
Badger Meter (BMI) Sees a More Significant Dip Than Broader Market: Some Facts to Know
zacks.com · Sep 10
2 Instruments Stocks Set to Profit From Industrial Automation Push
zacks.com · Sep 8
Jupiter Topco LLC Makes New $1.91 Million Investment in Badger Meter, Inc. $BMI
defenseworld.net · Sep 4
Badger Meter (BMI) Laps the Stock Market: Here's Why
zacks.com · Sep 3
BADGER METER, INC. (NYSE: BMI) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
globenewswire.com · Sep 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed September 16, 2026 · Live quote · Not investment advice